Coagulation factors are protein components of the blood which serve blood coagulation.
Search results 1 to 25 from a total of 101
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|---|---|---|---|
|
Haemate P 250 I.E. FVIII / 600 I.E. VWF |
CSL Behring GmbH |
2416.00.00 | 08.06.1982 | |
|
Haemate P 500 I.E. FVIII / 1200 I.E. VWF |
CSL Behring GmbH |
2416.01.00 | 08.06.1982 | |
|
Haemate P 1000 I.E. FVIII / 2400 I.E. VWF |
CSL Behring GmbH |
2416.02.00 | 08.06.1982 | |
|
IMMUNATE 500 I.E. |
Takeda GmbH |
3854.02.00 | 20.10.1983 | |
|
IMMUNATE 1000 I.E. |
Takeda GmbH |
3854.03.00 | 20.10.1983 | |
|
Alphanine 500 |
Grifols Deutschland GmbH |
6408.00.00 | 17.07.1985 | |
|
Alphanine 1000 |
Grifols Deutschland GmbH |
6408.01.00 | 17.07.1985 | |
|
Beriplex P/N 250 |
CSL Behring GmbH |
10500a/95 | 21.02.1996 | |
|
Octanate 250 |
OCTAPHARMA GmbH |
10500a/97-1 | 04.08.1998 | |
|
Octanate 500 |
OCTAPHARMA GmbH |
10500a/97-2 | 04.08.1998 | |
|
Octanate 1000 |
OCTAPHARMA GmbH |
10500a/97-3 | 04.08.1998 | |
|
Beriplex P/N 500 |
CSL Behring GmbH |
10501a/95 | 21.02.1996 | |
|
Beriplex P/N 1000 |
CSL Behring GmbH |
10501a/95a | 26.01.2013 | |
|
OCTANINE F 500 |
OCTAPHARMA GmbH |
10501a/97-2 | 07.09.2000 | |
|
OCTANINE F 1000 |
OCTAPHARMA GmbH |
10501a/97-3 | 07.09.2000 | |
|
Beriate 250 |
CSL Behring GmbH |
10505a/98-1 | 11.02.1998 | Rote-Hand-Brief: Beriate (09.08.2019) |
|
Beriate 500 |
CSL Behring GmbH |
10505a/98-2 | 11.02.1998 | Rote-Hand-Brief: Beriate (09.08.2019) |
|
Beriate 1000 |
CSL Behring GmbH |
10505a/98-3 | 11.02.1998 | Rote-Hand-Brief: Beriate (09.08.2019) |
|
Beriate 2000 |
CSL Behring GmbH |
10505a/98-4 | 11.12.2012 | Rote-Hand-Brief: Beriate (09.08.2019) |
|
Fanhdi 250 I.E. |
Grifols Deutschland GmbH |
10565a/97-1 | 12.08.1999 | |
|
Fanhdi 500 I.E. |
Grifols Deutschland GmbH |
10565a/97-2 | 12.08.1999 | |
|
Fanhdi 1000 I.E. |
Grifols Deutschland GmbH |
10565a/97-3 | 12.08.1999 | |
|
Haemoctin SDH 250 |
Biotest Pharma GmbH |
16841.00.00 | 06.11.1991 | |
|
Haemoctin SDH 500 |
Biotest Pharma GmbH |
16841.01.00 | 06.11.1991 | |
|
Haemoctin SDH 1000 |
Biotest Pharma GmbH |
16841.02.00 | 06.11.1991 |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 515 in BAnz AT 09.04.2024 B3.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 09.04.2024
